Human Amniotic Mesenchymal Stem Cells Promote Endogenous Bone Regeneration.

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Orthopedics

Background:

• Bone regeneration is a critical area in bone and joint medicine.
• Stem cell therapy offers an alternative to traditional bone defect reconstruction, improving efficacy and reducing side effects.
• Human amniotic mesenchymal stem cells (hAMSCs) possess potent paracrine functions beneficial for immune-regulation, anti-inflammation, and vascularized tissue regeneration.

Purpose of the Study:

• To review the source, characteristics, and regenerative roles of hAMSCs.
• To analyze the therapeutic effects and mechanisms of hAMSCs in promoting bone regeneration for joint diseases and bone defects.
• To evaluate the clinical application and prospects of hAMSC-based therapy.

Main Methods:

• Literature review of studies on hAMSCs.
• Analysis of hAMSC characteristics and functions.
• Examination of therapeutic effects and mechanisms in preclinical and clinical settings.

Main Results:

• hAMSCs exhibit significant potential in immune-regulation, anti-inflammation, and vascularized tissue regeneration.
• hAMSCs demonstrate therapeutic effects in promoting bone regeneration for joint diseases and bone defects.
• Current clinical trials suggest a promising, though still developing, application prospect for hAMSC-based therapies.

Conclusions:

• hAMSCs are a viable cell source for bone regeneration due to their regenerative properties.
• hAMSC-based therapy shows potential for treating bone defects and joint diseases.
• Further research and clinical validation are necessary to fully establish hAMSC therapy for bone diseases.